Why the South32 share price is at a 52-week low

The South32 Ltd (ASX: S32) share price has hit a new 52-week low. Is it time to buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The South32 Ltd (ASX: S32) share price has hit a new 52-week low today as investors scramble out of the stock. South32 has already had a tough 2019 so far – S32 shares started the year at $3.27 and got all the way up to $3.95 in March, before sliding down below the $3 level in mid-July. This trend has continued to where we see the share price today – a new 52-week low of $2.83.

So, what has happened to South32 to cause such a sentiment turn-around? 

A refresher on South32

South32 is the newest 'big' miner on the ASX, after it was spun-out of BHP Group Ltd (ASX: BHP) in 2015. BHP decided it wanted to focus on its 'core' commodities of coal, oil, copper and iron and so everything that didn't make this cut was bundled off into South32. This made the company a highly diversified miner from the start, with substantial assets in silver, lead, nickel, manganese and aluminium production.

As you may have picked up, South32 has little to no exposure to iron ore or gold. These two commodities have driven the largest resource gains on the ASX for 2019 so far, and so South32 has looked very boring for investors tripping over it to buy BHP or Fortescue Metals Group Ltd (ASX: FMG) shares.

Why have S32 shares gone south?

In addition to the reason above, plenty of investors are speculating that the combined interim and special dividends South32 paid out in February (9.6 cents per share) are unlikely to be repeated when the final 2019 dividend rolls around. South32 is facing commodity price headwinds for many of its products and volumes from one of its South African coal mines have been affected by equipment shortages and domestic demand.

In addition to this, the resumption of tensions in the US–China trade war last week (including reports China is set to ban all US food imports) is an anathema to export-dependent resource stocks like S32, which has become reliant on China's economic growth for earnings.

Foolish takeaway

Although there seem to be building headwinds on the horizon for South32, I still think that the company is a high-quality, low-cost and nicely diversified miner that might present a value opportunity at these share price levels. Personally, I will be keeping my eye on this one with great interest, especially on its upcoming dividend announcement.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »